657 Eblasakimab monotherapy improves moderate-to-severe atopic dermatitis symptoms across anatomical regions in a phase 1 study
- Resource Type
- Source
- Journal of Investigative Dermatology. 143:S112
- Subject
Cell Biology Dermatology Molecular Biology Biochemistry - Language
- ISSN
- 0022-202X